This site uses cookies. Some of these cookies are essential to the operation of the site, while others help to improve your experience by providing insights into how the site is being used. For more information, please see the ProZ.com privacy policy.
Cookie settings
Asked
Open questions
Answered
Asked | Open questions | Answered
Date Pair Term Level Status Answers (undeclined) Gloss
Jun 3 '22 eng>rus capture-recapture method on data pro closed 1 ok
May 30 '22 eng>rus Minimum Creditable Coverage Standards pro closed 2 ok
May 25 '22 eng>rus Participant creation in Complete Consent Portal pro closed 1 no
May 25 '22 eng>rus Safety Subset and Immuno Subset pro closed 2 no
May 25 '22 eng>rus abnormal neural activation pro closed 3 no
May 16 '22 eng>rus study withdrawal acknowledgment of pro closed 2 no
May 12 '22 eng>rus to reliably deliver on study objectives pro closed 2 no
May 12 '22 eng>rus model-based qualified relapse rate ratio pro closed 3 no
May 12 '22 eng>rus cleaning purposes pro closed 1 no
May 12 '22 eng>rus have significant representation pro closed 3 no
May 12 '22 eng>rus have missing visits and data pro closed 1 no
May 10 '22 eng>rus anti-Inducible T-cell Co-Stimulator receptor agonist humanised monoclonal antibo pro closed 1 no
May 6 '22 eng>rus catheter scraping or poking a hole pro closed 2 no
May 4 '22 eng>rus reset your account pro closed 3 no
Apr 28 '22 eng>rus to achieve their reasonable contribution pro closed 2 no
Apr 27 '22 eng>rus primary etiology of an acute coronary artery disease pathology pro closed 3 no
Apr 27 '22 eng>rus Strengthening generalisability pro closed 1 no
Apr 27 '22 eng>rus local laboratory MI diagnosis cut-off value pro closed 3 no
Apr 27 '22 eng>rus supply-demand mismatch pro closed 2 no
Apr 27 '22 eng>rus event accrual pro closed 2 no
Apr 22 '22 eng>rus 5-point grid pro closed 1 no
Apr 12 '22 eng>rus with the lump sum in vouchers pro closed 2 no
Apr 10 '22 eng>rus fix the vessel pro closed 2 no
Apr 9 '22 eng>rus Blood Outlet/Inlet pro closed 1 no
Apr 9 '22 eng>rus non-roll-in patients pro closed 1 no
Apr 9 '22 eng>rus roll-in group pro closed 1 no
Apr 9 '22 eng>rus sealed inside a protective shell pro closed 1 no
Apr 9 '22 eng>rus roll-in subject pro closed 1 no
Apr 7 '22 eng>rus for unapproved indication and off label use pro closed 3 no
Apr 7 '22 eng>rus unknown for covid-19 pro closed 2 no
Mar 22 '22 eng>rus amplified probe technique pro closed 2 no
Mar 17 '22 eng>rus National Beijing Center for Drug Safety Evaluation and Research pro closed 2 no
Mar 17 '22 eng>rus uterine gland hyperplasia pro closed 1 no
Mar 17 '22 eng>rus blank control group pro closed 1 no
Mar 17 '22 eng>rus LFTU visit window pro closed 2 no
Mar 8 '22 eng>rus ftbl. pro closed 1 no
Mar 7 '22 eng>rus than BY3 pro closed 2 no
Feb 28 '22 eng>rus Repeat Complex/Simple blood draw pro closed 1 ok
Feb 23 '22 eng>rus to evaluate safety and dosimetry pro closed 1 no
Feb 23 '22 eng>rus neither if anonymized pro closed 2 no
Feb 23 '22 eng>rus deliver strong radiation pro closed 3 no
Feb 22 '22 eng>rus rank order of affinity for binding to pro closed 3 no
Feb 22 '22 eng>rus is not extensively metabolized pro closed 2 no
Feb 22 '22 eng>rus worsening of seizures pro closed 1 no
Feb 22 '22 eng>rus intraneuronal stores pro closed 1 no
Feb 22 '22 eng>rus intraneuronal Ca2+ levels pro closed 3 no
Feb 12 '22 eng>rus Spiking Recovery pro closed 1 no
Feb 6 '22 eng>rus there are no pending for-cause regulatory audits pro closed 1 no
Jan 31 '22 eng>rus interval toxicity pro closed 2 no
Jan 31 '22 eng>rus properly equipped and staffed pro closed 2 ok
Asked | Open questions | Answered